Racial Differences in the Use of <EMPH>BRCA1/2</EMPH> Testing Among Women With a Family History of Breast or Ovarian Cancer
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
CONTEXT: Given the current context of racial disparities in health and health care and the historical context of eugenics, racial disparities in the use of genetic susceptibility testing have been widely anticipated. However, to our knowledge there are no published studies examining the magnitude and determinants of racial differences in the use of genetic susceptibility testing. OBJECTIVES: To investigate the relationship between race and the use of BRCA1/2 counseling among women with a family history of breast or ovarian cancer and to determine the contribution of socioeconomic characteristics, cancer risk perception and worry, attitudes about genetic testing, and interactions with primary care physicians to racial differences in utilization. DESIGN, SETTING, AND PARTICIPANTS: Case-control study (December 1999-August 2003) of 408 women with a family history of breast or ovarian cancer, of whom 217 underwent genetic counseling for BRCA1/2 testing (cases) and 191 women did not (controls). Participants received primary care within a large health system in greater Philadelphia, Pa. MAIN OUTCOME MEASURES: Probability of carrying a BRCA1/2 mutation, socioeconomic characteristics, perception of breast and ovarian cancer risk, worry about breast and ovarian cancer, attitudes about BRCA1/2 testing, and primary care physician discussion of BRCA1/2 testing were measured prior to undergoing BRCA1/2 counseling for cases and at the time of enrollment for controls. RESULTS: African American women with a family history of breast or ovarian cancer were significantly less likely to undergo genetic counseling for BRCA1/2 testing than were white women with a family history of breast or ovarian cancer (odds ratio, 0.22; 95% confidence interval, 0.12-0.40). This association persisted after adjustment for probability of BRCA1/2 mutation, socioeconomic characteristics, breast and ovarian cancer risk perception and worry, attitudes about the risks and benefits of BRCA1/2 testing, and primary care physician discussion of BRCA1/2 testing (adjusted odds ratio for African American vs white, 0.28; 95% confidence interval, 0.09-0.89). CONCLUSIONS: Racial disparities in the use of BRCA1/2 counseling are large and do not appear to be explained by differences in risk factors for carrying a BRCA1/2 mutation, socioeconomic factors, risk perception, attitudes, or primary care physician recommendations. The benefit of predictive genetic testing will not be fully realized unless these disparities can be addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the prevalence of BRCA1/2 mutations is comparable among most racial/ethnic groups except Ashkenazi Jews, racial/ethnic minorities and women from lower education or income levels are less likely to be referred to and receive genetic testing for these mutations [27, 28, 34, 68].”
From Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care (2018) · cites this paper as [68]
In the citing paper
“Although the prevalence of BRCA1/2 mutations is comparable among most racial/ethnic groups except Ashkenazi Jews, racial/ethnic minorities and women from lower education or income levels are less likely to be referred to and receive genetic testing for these mutations [27, 28, 34, 68].”
From Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care (2018) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,798
Unequal treatment: confronting racial and ethnic disparities in health care
(2003) · Choice Reviews Online · doi:10.5860/choice.40-5843 · Cited by 7,043
Capps, L. (2003) · JAMA · doi:10.1001/jama.290.18.2487-b · Cited by 4,526
Disseminating Innovations in Health Care
Berwick, D. M. (2003) · JAMA · doi:10.1001/jama.289.15.1969 · Cited by 1,878
Cancer Incidence in BRCA1 Mutation Carriers
Thompson, D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1358 · Cited by 1,096
Corbie-Smith, G., Thomas, S. B., & St. George, D. M. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.21.2458 · Cited by 1,072
Primary Care Physicians Who Treat Blacks and Whites
Bach, P. B., Pham, H. H., Schrag, D., Tate, R. C., & Hargraves, J. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmsa040609 · Cited by 986
Lerman, C. (1996) · JAMA · doi:10.1001/jama.1996.03530480027036 · Cited by 792
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., Gumpper, K. L., Scholl, T., Tavtigian, S. V., Pruss, D. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1480 · Cited by 558
Berry, D. A., Iversen, E. S., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., Lerman, C., Watson, P., Lynch, H. T., Hilsenbeck, S. G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.121 · Cited by 505
Ashton, C. M., Haidet, P., Paterniti, D. A., Collins, T. C., Gordon, H. S., O’Malley, K., Petersen, L. A., Sharf, B. F., Suarez-Almazor, M. E., Wray, N. P., et al. (2003) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2003.20532.x · Cited by 494
Psychological and Behavioral Implications of Abnormal Mammograms
Lerman, C., Track, B., Rimer, B. K., Boyce, A., Jepson, C., & Engstrom, P. F. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-8-657 · Cited by 481
Overview of Race and Hispanic Origin: Census 2000 Brief.
Grieco, E. M., & Cassidy, R. (2001) · Cited by 361
Development and testing of the health care system distrust scale
Rose, A., Peters, N., Shea, J. A., & Armstrong, K. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.21146.x · Cited by 297
Self-citationProphylactic Surgery Decisions and Surveillance Practices One Year Following BRCA1/2 Testing
Lerman, C., Hughes, C., Croyle, R. T., Main, D., Durham, C., Snyder, C., Bonney, A., Lynch, J. F., Narod, S. A., & Lynch, H. T. (2000) · Preventive Medicine · doi:10.1006/pmed.2000.0684 · Cited by 248
Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
Struewing, J. P., Lerman, C., Kase, R. G., Giambarresi, T. R., & Tucker, M. A. (1995) · PubMed · Cited by 214
Application of Breast Cancer Risk Prediction Models in Clinical Practice
Domchek, S. M., Eisen, A., Calzone, K., Stopfer, J., Blackwood, A., & Weber, B. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.007 · Cited by 201
Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk
Hughes, C., Gomez-Caminero, A., Benkendorf, J., Kerner, J., Isaacs, C., Barter, J., & Lerman, C. (1997) · Patient Education and Counseling · doi:10.1016/s0738-3991(97)00064-5 · Cited by 194
Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Thompson, H. S., Valdimarsdottir, H. B., Duteau-Buck, C., Guevarra, J. S., Bovbjerg, D. H., Richmond-Avellaneda, C., Amarel, D., Godfrey, D., Brown, K., & Offit, K. (2002) · PubMed · Cited by 183
Lerman, C. (1996) · JAMA · doi:10.1001/jama.275.24.1885 · Cited by 182
Breast cancer genetics in African Americans
Olopade, O. I., Fackenthal, J. D., Dunston, G., Tainsky, M. A., Collins, F., & Whitfield-Broome, C. (2003) · Cancer · doi:10.1002/cncr.11019 · Cited by 175
Grann, V. R., Jacobson, J. S., Thomason, D., Hershman, D. L., Heitjan, D. F., & Neugut, A. I. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.101 · Cited by 154
Tambor, E. S., Rimer, B. K., & Strigo, T. S. (1997) · American Journal of Medical Genetics · Cited by 153
Meijers-Heijboer, H., Brekelmans, C., Menke-Pluymers, M., Seynaeve, C., Baalbergen, A., Burger, C., Crepin, E., van den Ouweland, A. V. D., van Geel, B. V., & Klijn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.052 · Cited by 150
Ethnic differences in risk perception among women at increased risk for breast cancer
Hughes, C., Lerman, C., & Lustbader, E. D. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806000 · Cited by 143
Lerman, C., Hughes, C., Benkendorf, J., Biesecker, B. B., Kerner, J. F., Willison, J., Eads, N. L., Hadley, D. W., & Lynch, J. W. (1999) · PubMed · Cited by 140
The Association between Race and Attitudes about Predictive Genetic Testing
Peters, N., Rose, A., & Armstrong, K. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.361.13.3 · Cited by 139
Self-citationFactors associated with decisions about clinical BRCA1/2 testing.
Armstrong, K., Calzone, K., Stopfer, J. E., FitzGerald, G., Coyne, J. C., & Weber, B. (2000) · PubMed · Cited by 126
Self-citationThe Behavioral Risk Factor Surveillance System
Belanger, N. M. S. (2014) · The International Journal of Aging and Human Development · doi:10.1177/0091415015574184 · Cited by 116
Gao, Q. C., Tomlinson, G. E., Das, S., Cummings, S. A., Sveen, L., Fackenthal, J. D., Schumm, L. P., & Olopade, O. I. (2000) · Human Genetics · doi:10.1007/s004390000290 · Cited by 108
Likelihood of Undergoing Genetic Testing for Cancer Risk: A Population-Based Study
Bosompra, K., Flynn, B. S., Ashikaga, T., Rairikar, C. J., Worden, J. K., & Solomon, L. J. (2000) · Preventive Medicine · doi:10.1006/pmed.1999.0610 · Cited by 97
Gao, Q. C., Neuhausen, S. L., Cummings, S. A., Luce, M. C., & Olopade, O. I. (1997) · PubMed · Cited by 90
Hereditary cancer risk notification and testing: how interested is the general population?
Andrykowski, M. A., Lightner, R., Studts, J. L., & Munn, R. K. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.2139 · Cited by 77
Interest in BRCA1/2 Testing in a Primary Care Population
Armstrong, K., Weber, B., Ubel, P. A., Guerra, C. E., & Schwartz, J. S. (2002) · Preventive Medicine · doi:10.1006/pmed.2002.1022 · Cited by 72
Self-citationBRCA1/2 Genetic Testing in the Community Setting
Chen, W. Y., Garber, J. E., Higham, S., Schneider, K. A., Davis, K. B., Deffenbaugh, A. M., Frank, T. S., Gelman, R. S., & Li, F. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.147 · Cited by 58
Utilization of BRCA1/2 genetic testing in the clinical setting
Lee, S. C., Bernhardt, B. A., & Helzlsouer, K. J. (2002) · Cancer · doi:10.1002/cncr.10420 · Cited by 58
Eugenics and genetic discrimination.
Holtzman, N. A., & Rothstein, M. A. (1992) · Europe PMC (PubMed Central) · Cited by 49
Early use of clinical BRCA1/2 testing: Associations with race and breast cancer risk
Armstrong, K., Weber, B., Stopfer, J. E., Calzone, K., Putt, M., Coyne, J., & Schwartz, J. S. (2002) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10928 · Cited by 45
Self-citationBeliefs about Breast Cancer Risk and Use of Postmenopausal Hormone Replacement Therapy
Armstrong, K., Popik, S., Guerra, C. E., & Ubel, P. A. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000307 · Cited by 21
Self-citation
Cited by
Lippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
Fackenthal, J. D., & Olopade, O. I. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2054 · Cited by 488
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Doubeni, C. A., Epling, J. W., Kubik, M., et al. (2019) · JAMA · doi:10.1001/jama.2019.10987 · Cited by 467
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2747 · Cited by 409
Hall, M. J., Reid, J. E., Burbidge, L. A., Pruss, D., Deffenbaugh, A. M., Frye, C., Wenstrup, R. J., Ward, B. E., Scholl, T. A., & Noll, W. W. (2009) · Cancer · doi:10.1002/cncr.24200 · Cited by 365
Metadata
- Authors
- Armstrong, K.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-04-13
- Volume
- 293
- Issue
- 14
- Pages
- 1729
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2056008497
- Cited by
- 432
- References
- 39
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.